White and Brown Adipose Depot Collection from Mouse Pup: A Surgical Procedure to Harvest the White Adipose Tissue and Brown Adipose Tissue from Mouse Pup

Executive Industry Relevance

This surgical procedure enables the isolation of white and brown adipose tissues from mouse pups, providing a foundational model for metabolic research in biopharma. Access to these depots supports target validation in obesity, diabetes, and thermoregulation pathways. The method enhances predictive confidence by supplying disease-relevant tissue for preclinical de-risking.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Scientific Value: Enables interrogation of adipose tissue biology and therapeutic hypothesis testing in metabolic disease models.
• Operational Value: Provides a reproducible source of primary adipocytes for pathway clarification and target engagement studies.

Screening & Assay Development

• Scientific Value: Supplies primary white and brown adipocytes for developing functional assays measuring lipid storage and thermogenic activity.
• Operational Value: Ensures tissue consistency and viability for high-throughput screening of metabolic modulators.

Translational & Preclinical Research

• Scientific Value: Facilitates disease-relevant system modeling to study adipose tissue dysfunction in obesity and insulin resistance.
• Operational Value: Supports preclinical validation of compounds targeting WAT browning or BAT activation.

Pipeline & Workflow Integration

The harvested adipose tissues serve as a discovery biology resource that informs lead identification and preclinical progression in metabolic drug development.

• Discovery Biology: Enables hypothesis testing on adipocyte differentiation, lipid metabolism, and thermogenic capacity.
• Screening: Provides standardized primary cell preparations for assay development and compound profiling.
• Analytics: Yields quantitative readouts such as lipid accumulation, mitochondrial respiration, and gene expression for mechanism of action studies.
• Translational Research: Connects in vitro findings to whole-animal physiology through disease-relevant adipose tissue models.
• Enterprise Reuse: Establishes a scalable tissue isolation platform applicable across multiple metabolic targets and therapeutic areas.

Operational & Enterprise Impact

• Scientific Value: Increases target confidence through direct interrogation of human-relevant adipose tissue biology.
• Operational Value: Promotes reproducibility and standardization in adipose tissue-based assays across laboratories.
• Strategic Value: Reduces mechanistic ambiguity in early metabolic programs, improving go/no-go decision quality.
• Portfolio Impact: Enables risk-adjusted prioritization of compounds modulating adipose tissue function.

Implementation Considerations

• Requires expertise in rodent surgical techniques and adipose tissue identification.
• Dependent on sterile dissection tools and temperature-controlled buffers to maintain tissue integrity.
• Necessitates coordination between animal care, surgical, and analytical teams for timely tissue processing.
• Must account for developmental variability in neonatal adipose tissue yield and composition.
• Limited by the small tissue mass obtainable from mouse pups, constraining downstream assay multiplexing.

Biopharma FAQs